Gemcitabine-associated scleroderma-like changes of the lower extremities

Journal of the American Academy of Dermatology

Volumn 51, Issue 2, 2004, Pages 73-76

  Bessis, Didier ^a   Guillot, Bernard ^a   Legouffe, Eric ^a   Guilhou, Jean Jacques ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; AMITRIPTYLINE; CISPLATIN; CLONAZEPAM; DOXORUBICIN; METHOTREXATE; MORPHINE; PARACETAMOL; VINBLASTINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; ANAMNESIS; ARTICLE; BLADDER METASTASIS; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; DRUG WITHDRAWAL; EDEMA; FASCIA DISEASE; FIBROSIS; HUMAN; HUMAN TISSUE; LABORATORY TEST; LEG DISEASE; MALE; MUSCLE DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCLERODERMA; SCLEROSIS; SKIN BIOPSY; AUTOPSY; BLADDER CARCINOMA; CORRELATION ANALYSIS; CYSTECTOMY; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; LEG; LEUKOCYTE COUNT; LUNG METASTASIS; LYMPHOCYTIC INFILTRATION; MUSCLE BIOPSY; PUNCH BIOPSY; SIDE EFFECT; THROMBOCYTE COUNT; TREATMENT FAILURE; BIOPSY; BONE TUMOR; CHEMICALLY INDUCED DISORDER; DERMIS; DIFFUSE SCLERODERMA; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; TRANSITIONAL CELL CARCINOMA;

ACETAMINOPHEN; AMITRIPTYLINE; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; BONE NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; CLONAZEPAM; DEOXYCYTIDINE; DERMIS; DOXORUBICIN; EDEMA; HUMANS; INFUSIONS, INTRAVENOUS; LEG; LUNG NEOPLASMS; MALE; METHOTREXATE; MIDDLE AGED; MORPHINE; SCLERODERMA, DIFFUSE; VINBLASTINE;

EID: 3242736863     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2001.07.001     Document Type: Article

References (16)

1. Hertel L.W., Boder G.B., Kroin J.S., Rinzel S.M., Poore G.A., Todd G.C., et al. Evaluation of the antitumor activity of gemcitabine. Cancer Res. 50:1990;4417-4422
2. Huang P., Chubb S., Hertel L.W., Grindey G.B., Plunkett W. Action of gemcitabine on DNA synthesis. Cancer Res. 51:1991;6110-6117
3. Carmichael J. The role of gemcitabine in the treatment of other tumours. Br J Cancer. 78:1998;21-25
4. Moore M.J., Tannock I.F., Ernst D.S., Huan S., Murray N. Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer. J Clin Oncol. 15:1977;3441-3445
5. Sternberg C.N. Gemcitabine in bladder cancer. Semin Oncol. 27:2000;31-39
6. Aapro M.S., Martin C., Hatty S. Gemcitabine-a safety review. Anticancer Drugs. 9:1998;191-201
7. Hejna M., Valencak J., Raderer M. Anal pruritus after cancer chemotherapy with gemcitabine. N Engl J Med. 340:1999;655-656
8. Geffen D., Horowitz J. Gemcitabine-induced severe extremity edema with muscle contractures and subsequent prevention with prednisone. Isr Med Assoc J. 2:2000;552-553
9. Brandes A., Reichmann U., Plasswilm L., Bamberg M. Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine-a report of three cases. Anticancer Drugs. 11:2000;15-17
10. Haustein U.F., Haupt B. Drug-induced scleroderma and sclerodermiform conditions. Clin Dermatol. 16:1998;353-366
11. Kerr L.D., Spiera H. Scleroderma in association with the use of bleomycin: a report of 3 cases. J Rheumatol. 19:1992;294-296
12. Kono T., Ishii M., Negoro N., Taniguchi S. Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent. J Am Acad Dermatol. 42:2000;519-520
13. Sheishima M., Izumi T., Kanoh H. Raynaud's phenomenon possibly induced by a compound drug of tegafur and uracil. Eur J Dermatol. 9:1999;55-58
14. Marck Y., Meunier L., Barnéon G., Meynadier J. Scleroderma of the shoulders after treatment with combined bleomycin and radiotherapy. Ann Dermatol Venereol. 121:1994;712-714
15. Battafarano D.F., Zimmerman G.C., Older S.A.Z., Keeling J.H., Burris H.A. Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. Cancer. 76:1995;110-115
16. Cleveland M.G., Ajaikumar B.S., Reganti R. Cutaneous fibrosis induced by docetaxel: a case report. Cancer. 88:2000;1078-1081